ClearPoint Neuro, Inc. (CLPT)
NASDAQ • Healthcare
Last close at September 4, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 62 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (NASDAQ: CLPT) develops and commercializes medical devices for minimally invasive brain surgery guided by real-time MRI, centered on tools that help clinicians place instruments and therapies inside the brain. In FY2025, the company generated $37.0 million in revenue.
Today's Snapshot
CLPT closed 0.6% below yesterday's close, in line with a weaker sector. Shares changed hands at about two-thirds of its usual level. Analysts cut ClearPoint Neuro’s price target as heavier investment spending weighs on near-term execution.
Trading Volume
Below 10d avg (594.1K)
381.6K
vs S&P 500 Today
Moderate Underperformance
-0.22%
Updated: September 4, 2026 at 20:01 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$14.55 - $15.04Sell
- RSI (14)40.66Neutral
- Stochastic %K (14, 3, 3)4.31Buy
- MACD Level (12, 26)-0.17Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.